CellOracle-guided zebrafish perturbations identify axial-mesoderm effects of noto and lhx1a loss
The CellOracle machine-learning workflow used single-cell gene-regulatory networks to prioritize transcription factors for perturbation in zebrafish development. CRISPR/Cas9 tests confirmed a model-predicted, previously unreported increase in prechordal-plate differentiation after loss of noto, alongside the known loss of notochord. Model-prioritized lhx1a loss also inhibited axial-mesoderm differentiation: single-cell RNA-seq found expansion of early notochord cells and reductions in later notochord and prechordal-plate populations; orthogonal RNA assays supported reduced notochord/prechordal markers.
Technology: CellOracle, a machine-learning gene-regulatory-network model with in-silico transcription-factor perturbation
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: CRISPR/Cas9 tests confirmed a model-predicted, previously unreported increase in prechordal-plate differentiation after loss of noto, alongside the known loss of notochord.
- Still unknown: Evidence is from zebrafish crispants during embryonic development, not stable mutants or mammalian/human systems; the authors report no gross morphological change despite transcriptomic/cell-population effects. The CellOracle model depends on inferred networks and makes cell-state-shift predictions, not direct causal proof of all inferred edges. A later unreviewed 2024 preprint raises implementation and benchmarking concerns, particularly about its use of ATAC-seq for distal regulatory interactions and comparisons with other GRN tools; this record relies only on the specific perturbation predictions tested experimentally and does not adopt the paper's broader benchmarking claims.
- AI role: The model built context-specific networks from single-cell data, simulated transcription-factor loss, and prioritized noto and lhx1a for experimental follow-up. Researchers used CRISPR/Cas9 crispants, single-cell RNA-seq and marker assays to test the predicted zebrafish cell-fate effects; the prechordal-plate increase after noto loss was reported as previously unrecognized.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC9946838/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 766 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.